372 related articles for article (PubMed ID: 16456008)
1. Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.
Mallevaey T; Zanetta JP; Faveeuw C; Fontaine J; Maes E; Platt F; Capron M; de-Moraes ML; Trottein F
J Immunol; 2006 Feb; 176(4):2476-85. PubMed ID: 16456008
[TBL] [Abstract][Full Text] [Related]
2. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice.
Faveeuw C; Angeli V; Fontaine J; Maliszewski C; Capron A; Van Kaer L; Moser M; Capron M; Trottein F
J Immunol; 2002 Jul; 169(2):906-12. PubMed ID: 12097395
[TBL] [Abstract][Full Text] [Related]
4. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
5. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
6. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology.
Vanhoutte F; Breuilh L; Fontaine J; Zouain CS; Mallevaey T; Vasseur V; Capron M; Goriely S; Faveeuw C; Ryffel B; Trottein F
Microbes Infect; 2007; 9(14-15):1606-13. PubMed ID: 18023390
[TBL] [Abstract][Full Text] [Related]
8. Defined Intestinal Regions Are Drained by Specific Lymph Nodes That Mount Distinct Th1 and Th2 Responses Against
Mayer JU; Brown SL; MacDonald AS; Milling SW
Front Immunol; 2020; 11():592325. PubMed ID: 33193437
[TBL] [Abstract][Full Text] [Related]
9. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid Dendritic Cells Facilitate Th Cell Cytokine Responses throughout
Webb LM; Phythian-Adams AT; Costain AH; Brown SL; Lundie RJ; Forde-Thomas J; Cook PC; Jackson-Jones LH; Marley AK; Smits HH; Hoffmann KF; Tait Wojno ED; MacDonald AS
Immunohorizons; 2021 Aug; 5(8):721-732. PubMed ID: 34462311
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
[TBL] [Abstract][Full Text] [Related]
12. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection.
Wiethe C; Debus A; Mohrs M; Steinkasserer A; Lutz M; Gessner A
J Immunol; 2008 Apr; 180(7):4371-81. PubMed ID: 18354157
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
16. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
Hernandez HJ; Wang Y; Stadecker MJ
J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498
[TBL] [Abstract][Full Text] [Related]
17. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
Patterson S; Chaidos A; Neville DC; Poggi A; Butters TD; Roberts IA; Karadimitris A
J Immunol; 2008 Sep; 181(5):3268-76. PubMed ID: 18713998
[TBL] [Abstract][Full Text] [Related]
18. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni.
Pearce EJ; M Kane C; Sun J; J Taylor J; McKee AS; Cervi L
Immunol Rev; 2004 Oct; 201():117-26. PubMed ID: 15361236
[TBL] [Abstract][Full Text] [Related]
19. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
20. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
